following a hypothesis to increase the probability of treatment efficacy in multiple myeloma
Published 4 years ago • 95 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
5:22
novel target antigens to improve the efficacy of immunotherapeutics in multiple myeloma
-
55:48
hitting the bcma target in multiple myeloma
-
4:41
case 2: overcoming high risk in myeloma
-
40:06
multiple myeloma: a pathway to better outcomes
-
20:12
personalized medicine in multiple myeloma: the latest treatment advancements
-
1:46
lenalidomide vs. placebo for multiple myeloma patients following a single asct
-
4:00
determination: analysis of pfs benefit in different patient populations
-
5:46
adam d. cohen, md: expanding car t cells to treat myeloma
-
1:04:23
navigating from a to b and c in multiple myeloma
-
47:18
diagnosis and risk assessment in multiple myeloma
-
5:53
daratumumab revolutionizing how myeloma is treated
-
35:50
dr. paul richardson on novel approaches for treating multiple myeloma | dana-farber cancer institute
-
47:17
new directions in treating multiple myeloma in the era of novel agents
-
1:39
dr. borrello sheds light on the multiple myeloma treatment paradigm
-
36:17
update on multiple myeloma treatment: kenneth c. anderson, md
-
2:46
what key tests should follow a myeloma diagnosis?
-
51:36
relapsed refractory multiple myeloma | current treatment options | options on the horizon
-
5:20
follow-up and mrd testing in high-risk myeloma
-
5:28
how i treat relapsed/refractory multiple myeloma - kenneth anderson, md